ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Somatuline
C56H73N11O12S2
1156.4 g/mol
APIWarning

Lanreotide acetate

CAS127984-74-1
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Lanreotide acetate is a complex cyclic octapeptide salt used as an active pharmaceutical ingredient in the manufacture of pharmaceutical products. This compound is characterized by multiple amide bonds, aromatic rings, and a disulfide bridge, and it is supplied as a salt form for research and manufacturing applications.

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Lanreotide acetate?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongSame Parent

Lanreotide

CAS108736-35-2

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.78

Vapreotide

CAS103222-11-3

pharmaceutical raw material

ReferenceSame Category

Ursodiol

CAS128-13-2

pharmaceutical raw material

ReferenceSame Category

Noscapine

CAS128-62-1

pharmaceutical raw material

ReferenceSame Category

3-(Aminomethyl)-5-methylhexanoic acid

CAS128013-69-4

pharmaceutical raw material

ReferenceSame Category

(R)-citalopram

CAS128196-02-1

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Health Hazard
Health Hazard
Warning
H361Suspected of damaging fertility or the unborn child
Identifiers
IUPAC Name

acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide

InChIKey

DEXPIBGCLCPUHE-UISHROKMSA-N

SMILES

C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(C)C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)N)O.CC(=O)O

Synonyms (8)
  • Lanreotide acetate
  • Somatuline
  • Somatuline Autogel
  • Somatuline Depot
  • Somatuline LP

Sourcing Lanreotide acetate?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→